Barry A. Borlaug
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Cardiac Valve Diseases and Treatments
- Cardiac pacing and defibrillation studies
- Complementary and alternative medicine top 0.02%
- Cardiovascular and exercise physiology
Papers in
-
- Cardiovascular Function and Risk Factors 296
- Heart Failure Treatment and Management 120
- Cardiac pacing and defibrillation studies 45
- Cardiac Valve Diseases and Treatments 45
-
- Cardiovascular and exercise physiology 50
- Co-authors
- Margaret M. Redfield (79 shared papers)Yogesh N.V. Reddy (150 shared papers)Vojtěch Melenovský (64 shared papers)Masaru Obokata (79 shared papers)David A. Kass (21 shared papers)Carolyn S.P. Lam (26 shared papers)Thomas Patrick Olson (38 shared papers)Richard J. Rodeheffer (10 shared papers)
- Journals
- European Journal of Heart Failure (76 papers)Journal of the American College of Cardiology (71 papers)Circulation Heart Failure (52 papers)Journal of Cardiac Failure (46 papers)European Heart Journal (42 papers)
- Partner nations
- United StatesDenmarkCzechia
In The Last Decade
Barry A. Borlaug
568 papers receiving 42.1k citations
Barry A. Borlaug's Hit Papers
Peers
Comparison fields: 5 of 153
- Cardiology and Cardiovascular Medicine 28.1k
- Complementary and alternative medicine 2.8k
- Endocrinology, Diabetes and Metabolism 4.5k
- Pulmonary and Respiratory Medicine 7.3k
- Radiology, Nuclear Medicine and Imaging 3.0k
Countries citing papers authored by Barry A. Borlaug
This map shows the geographic impact of Barry A. Borlaug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Borlaug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Borlaug more than expected).
Fields of papers citing papers by Barry A. Borlaug
This network shows the impact of papers produced by Barry A. Borlaug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Borlaug. The network helps show where Barry A. Borlaug may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry A. Borlaug, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 605 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2009 | 1106 |
| 2 | Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity Hit paper breakdown → | 2023 | 1070 |
| 3 | Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2013 | 965 |
| 4 | Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2017 | 920 |
| 5 | Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2010 | 914 |
| 6 | A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2018 | 904 |
| 7 | Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension Hit paper breakdown → | 2006 | 872 |
| 8 | Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Hit paper breakdown → | 2010 | 872 |
| 9 | Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2016 | 783 |
| 10 | Age- and Gender-Related Ventricular-Vascular Stiffening Hit paper breakdown → | 2005 | 687 |
| 11 | Heart Failure With Preserved Ejection Fraction In Perspective Hit paper breakdown → | 2019 | 623 |
| 12 | Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2010 | 602 |
| 13 | The pathophysiology of heart failure with preserved ejection fraction Hit paper breakdown → | 2014 | 577 |
| 14 | Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction Hit paper breakdown → | 2006 | 571 |
| 15 | Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Hit paper breakdown → | 2024 | 526 |
| 16 | Right heart dysfunction in heart failure with preserved ejection fraction Hit paper breakdown → | 2014 | 518 |
| 17 | Evaluation and management of heart failure with preserved ejection fraction Hit paper breakdown → | 2020 | 482 |
| 18 | Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Hit paper breakdown → | 2024 | 468 |
| 19 | Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2016 | 465 |
| 20 | The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial Hit paper breakdown → | 2021 | 454 |
About Barry A. Borlaug
Barry A. Borlaug is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 605 papers that have together received 43.4k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (296 papers), Heart Failure Treatment and Management (120 papers), Pulmonary Hypertension Research and Treatments (78 papers), Cardiovascular and exercise physiology (50 papers), Cardiac pacing and defibrillation studies (45 papers), Cardiac Valve Diseases and Treatments (45 papers), Diabetes Treatment and Management (35 papers) and Congenital Heart Disease Studies (32 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (28.1k citations), Complementary and alternative medicine (2.8k citations), Endocrinology, Diabetes and Metabolism (4.5k citations), Pulmonary and Respiratory Medicine (7.3k citations) and Radiology, Nuclear Medicine and Imaging (3.0k citations). Barry A. Borlaug has collaborated with scholars based in United States, Denmark and Czechia. Frequent co-authors include Margaret M. Redfield, Yogesh N.V. Reddy, Vojtěch Melenovský, Masaru Obokata, David A. Kass, Carolyn S.P. Lam, Thomas Patrick Olson, Richard J. Rodeheffer, Walter J. Paulus and Rick A. Nishimura. Their work appears in journals such as European Journal of Heart Failure, Journal of the American College of Cardiology, Circulation Heart Failure, Journal of Cardiac Failure and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.